BIOMAT Database Logo BIOMAT Database Logo

A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders. 1982

G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations

Related Publications

G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
Chronic lymphocytic leukaemia and its relationship to other lymphoproliferative disorders.
February 1977, Clinics in haematology,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
A hemalog D analysis of chronic lymphocytic leukaemia and other lymphoproliferative disorders affecting the blood.
May 1981, Journal of clinical pathology,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders.
February 2016, Clinics in geriatric medicine,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.
December 2007, British journal of haematology,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
Lymphoproliferative disorders of the orbit: an immunological approach to diagnosis and pathogenesis.
September 1983, The British journal of ophthalmology,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
January 1983, African journal of medicine and medical sciences,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
Chronic lymphoproliferative disorders at an Indian tertiary cancer centre - the panel sufficiency in the diagnosis of chronic lymphocytic leukaemia.
July 2013, Journal of clinical and diagnostic research : JCDR,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
[Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
January 1995, Acta haematologica Polonica,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lymphoproliferative disorders.
December 1975, Scandinavian journal of haematology,
G Pizzolo, and A Ambrosetti, and G Rossetti, and L S Zampini, and F Menestrina, and M Chilosi, and G Perona
Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders.
March 2010, Translational oncogenomics,
Copied contents to your clipboard!